GoResp Digihaler

budesonide/formoterol fumarate dihydrate · Teva Pharma B.V.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GoResp Digihaler, covering 2025-02-18 to 2025-02-18. Get the full timeline:

Most recent: EMA Authorised: GoResp Digihaler (previously Budesonide/Formoterol Teva Pharma B.V.) (Budesonide;formoterol fumarate dihydrate) — Teva Pharma B.V.

See pricing